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Abstract
Clonal deletion of autoreactive B cells is crucial to prevent autoimmunity, but the signaling 
mechanisms that regulate this checkpoint remain undefined. Here we characterized a previously 
unrecognized Ca2+-driven Erk activation pathway, which was pro-apoptotic and biochemically 
distinct from DAG-induced Erk activation. This pathway required PKCδ and RasGRP proteins 
and depended on Stim1 concentrations, which control the magnitude of Ca2+ entry. 
Developmental regulation of these proteins was associated with selective activation of the 
pathway in B cells prone to negative selection. This checkpoint was impaired in PKCδ-deficient 
mice, which developed B cell autoimmunity. Conversely, Stim1 overexpression conferred a 
competitive disadvantage to developing B cells. These findings establish Ca2+-dependent Erk 
signaling as a critical pro-apoptotic pathway that mediates B cell negative selection.
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Early B cell development in the bone marrow is characterized by genetic rearrangements of 
the immunoglobulin locus that lead to the production of a unique B cell receptor (BCR) on 
the surface of each B cell. This process generates an exceptionally diverse repertoire of B 
cells for the recognition of potential foreign invaders. However, a sizeable portion of the 
initial repertoire has the ability to recognize self and these cells must be modified, silenced 
or eliminated to prevent later autoimmunity1–5. Immature bone marrow B cells initially 
express the BCR as membrane-bound IgM, establishing the first opportunity for the cell to 
recognize antigen. Antigen engagement at this stage results in upregulation of the 
recombination machinery and receptor editing, one way by which autoreactivity can be 
avoided while rescuing the cell6. However, as cells progress through development and 
continue increasing the surface abundance of IgM and IgD, they lose the ability to edit the 
receptor and instead become increasingly sensitive to antigen-induced apoptosis7. These 
transitional bone marrow cells thus undergo apoptosis upon antigen encounter, a second 
checkpoint to avoid the development of later autoimmunity. Cells that survive past this stage 
then leave the bone marrow and migrate to the spleen, where they undergo additional 
selection checkpoints before completing maturation. Once B cells reach a mature stage, they 
become resistant to antigen-induced apoptosis and instead mount vigorous proliferative 
responses to antigen. Therefore, developmental changes during B cell maturation alter 
signaling responses to antigen in ways that lead to different functional outcomes. The 
molecular mechanisms by which antigen encounter leads to editing, apoptosis or 
proliferation at different stages of B cell development are not well understood.
Compared to mature B cells, developing B cells display decreased diacylglycerol (DAG) 
production and increased amplitude and duration of Ca2+ entry in response to antigen, 
particularly at low antigen concentrations8–11. Ca2+ is essential for both receptor editing and 
antigen-induced apoptosis7, implying that increased amplitude of Ca2+ entry in developing 
B cells likely contributes to their increased sensitivity to antigen-induced apoptosis. The 
mechanism that drives Ca2+ into a lymphocyte is initiated by depletion of intracellular 
stores: antigen receptor crosslinking leads to activation of phospholipase C-γ (PLC-γ), 
which converts PtdIns(4,5)P2 into Ins(1,3,4)P3 and DAG; IP3 then binds IP3 receptors on the 
endoplasmic reticulum (ER) membranes, leading to depletion of Ca2+ from the ER stores. 
This triggers an initial increase in cytoplasmic Ca2+ concentration, which is followed by 
opening of the Ca2+ release activated Ca2+ (CRAC) channels (or other SOC channels, such 
as TRP channels, depending on the cell type) at the plasma membrane. Extracellular Ca2+ 
then flows into the cell following a ten-thousand-fold gradient and further prolongs the 
increases in intracellular Ca2+ concentration, a process is known as store-operated Ca2+ 
entry (SOCE)12. The mechanism that couples ER store release to opening of the plasma 
membrane channels has only recently been defined, in part due to the identification of Stim1 
as the long-sought ER Ca2+ sensor13–15. Stim1 is a transmembrane ER protein that contains 
a Ca2+-binding EF hand localized in the lumen of the ER. Under resting conditions, Stim1 is 
Ca2+-bound and evenly distributed through the ER membrane. Upon release of the ER Ca2+ 
stores Stim1 becomes Ca2+ unbound, clusters and moves toward the plasma membrane 
where it interacts with the channels16–20, causing them to open and triggering entry of 
extracellular Ca2+. Stim1 is thus essential for SOCE, but the extent to which Stim1 protein 
abundance influences the potential magnitude of Ca2+ responses has not been explored.
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Here we used Stim1 to establish a system for sensitization of B cells to antigen receptor-
induced apoptosis. Using this system we identified and characterized a previously 
unrecognized Ca2+-driven pathway involved in Erk activation. We demonstrated that Stim1 
overexpression in a B cell line augmented the amplitude and duration of Ca2+ entry and 
enhanced antigen receptor-induced apoptosis. By mass spectrometry we identified a Ca2+-
dependent pathway to Erk with biochemical requirements distinct from those for DAG-
mediated Erk activation. Activation of this Ca2+-dependent pathway required RasGrp and 
PKCδ activity, and its disruption rescued the cells from antigen receptor-induced apoptosis. 
Furthermore, we identified S332 on human RasGRP1 as a potential phosphorylation site that 
is a likely target for protein kinase Cδ and was essential for activation of this Ca2+-Erk 
pathway. Stim1, PKCδ and RasGRP proteins were all differentially expressed in primary 
bone marrow B cells prone to negative selection and as a result, this pathway was selectively 
activated in these B cell subsets. PKCδ-deficient developing B cells failed to activate this 
pathway, which correlates with development of self-reactive B cells and autoimmunity in 
these mice21, 22. In contrast, developing B cells overexpressing Stim1 displayed increased 
negative selection at the bone marrow transitional stage, and this effect required PKCδ. Our 
findings demonstrate that DAG and Ca2+ can direct Erk signaling towards different 
functional outcomes, thus outlining a molecular mechanism by which developmental 
regulation of Ca2+- and DAG-dependent Erk pathways can determine B cell fate.
Results
Stim1 increases SOCE and apoptosis in DT40 B cells
Recent work has described an important role for Stim1 in store-operated Ca2+ entry 
(SOCE)13–15. We hypothesized that Stim1 might act as the limiting factor to control the rate 
of CRAC channel opening and thus control induction of apoptosis. Indeed, DT40 B cells 
stably over-expressing eYFP-Stim1 (Supplementary Fig. 1) displayed increased amplitude 
and duration of SOCE relative to wild-type DT40 cells in response to either BCR 
stimulation, thapsigargin or cyclopiazonic acid (CPA) (Fig. 1a, Supplementary Fig. 2a). 
Thapsigargin and CPA trigger SOCE by inhibiting the SERCA pumps in the ER, thereby 
inducing passive release of Ca2+ from the ER stores while bypassing proximal BCR 
signaling. Consistent with a role for Ca2+ in antigen-induced apoptosis8, 10, Stim1 
overexpression sensitized DT40 cells to both BCR- and thapsigargin-induced apoptosis (Fig. 
1b). Furthermore, chelating extracellular Ca2+ with EGTA during either stimulation regimen 
rescued the cells from apoptosis. Therefore, Ca2+-dependent pro-apoptotic signals are 
enhanced in Stim1-overexpressing DT40 cells.
Increased SOCE leads to Ca2+-dependent Erk activation
We examined the phosphotyrosine profile of Stim1-overexpressing DT40 B cells following 
thapsigargin stimulation for 2 and 5 minutes and observed robust and sustained tyrosine 
phosphorylation of a ~42 kDa band, which was only modestly detectable in thapsigargin-
stimulated wild-type DT40 cells (Fig. 1c). Immunoprecipitation of this protein with a 
phosphotyrosine antibody (Fig. 1d), followed by mass spectrometry identified this band as 
Erk2. To confirm the identity of this protein, DT40 cells or Stim1-overexpressing DT40 
cells were stimulated over time with thapsigargin or CPA in the presence or absence of 
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extracellular Ca2+, and the phospho-Erk (pErk) responses were analyzed by flow cytometry. 
While Ca2+-dependent Erk activation was modest and short-lived in wild-type DT40, it was 
robust and sustained in Stim1-overexpressing DT40 cells (Fig. 1e,f, Supplementary Fig. 2b). 
Chelation of extracellular Ca2+ by EGTA effectively abrogated the thapsigargin- or CPA-
induced pErk response, demonstrating that the robust Erk activation observed in the Stim1-
overexpressing DT40 cells is due to the increased SOCE in these cells.
Antigen-induced Erk activation in lymphocytes is thought to be DAG-dependent and mostly 
Ca2+-independent23–27. However, we hypothesized that a parallel, Ca2+-driven pathway to 
Erk may become relevant in B cells when the SOCE is more intense relative to the limited 
DAG signals10, and longer lasting than the DAG signal. Stim1-overexpressing DT40 cells 
had increased and prolonged pErk production in response to BCR stimulation with respect to 
wild-type DT40 cells, and the increased amplitude and duration of the response depended on 
extracellular Ca2+ (Fig. 2a,b). To determine whether this pathway to Erk is predominantly 
triggered by Ca2+ and less by DAG, we utilized diacylglycerol kinase ζ (DGKζ), which 
converts DAG to phosphatidic acid, thereby inhibiting DAG-dependent responses28. We 
transfected Stim1-overexpressing DT40 cells with DGKζ and CD16 as a surrogate cell 
surface marker for transfected cells. The cells were then stimulated with either thapsigargin 
or a dose of anti-BCR that elicits an equivalent pErk response in the untransfected 
population (Fig. 2c,d). DGKζ expression did not inhibit thapsigargin-induced Ca2+-
dependent pErk (Fig. 2c,d). In contrast, BCR crosslinking, which triggers DAG production 
as well as SOCE, elicited a pErk response that was partially inhibited by DGKζ. Addition of 
EGTA at the time of BCR crosslinking led to further inhibition of the pErk response, 
demonstrating that simultaneous inhibition of Ca2+ and DAG can almost entirely ablate Erk 
activation in these cells. Thus, BCR stimulation can activate Erk via distinct DAG- or Ca2+-
dependent pathways and the kinetics of Ca2+ entry and DAG production affect the relative 
contribution of these pathways to the overall response.
Ca2+-Erk signaling in bone marrow developing B cells
We next investigated whether the activation of this Ca2+-Erk pathway that we observed in 
our DT40 B cell model with Stim1 expression also occurs in primary B cells. Bone marrow 
cells from wild-type C57BL/6 mice were stimulated with thapsigargin over time, fixed, 
permeabilized, stained for pErk in combination with cell surface markers and analyzed by 
flow cytometry. Only immature and transitional B cells, but not earlier precursors or mature 
recirculating B cells, displayed robust Ca2+-dependent Erk activation (Fig. 3). Ca2+-
dependent Erk activation was less robust in splenic transitional subsets than in bone marrow 
immature and transitional cells (data not shown), suggesting that this pathway is more 
relevant in the bone marrow. Thus, B cells are altered developmentally to allow the 
activation of this pathway specifically in bone marrow B cell populations known to be 
highly sensitive to apoptosis, where an important checkpoint for the deletion of self-reactive 
B cells occurs.
Loss of Stim1-overexpressing developing B cells
We next hypothesized that, similar to the effect observed in DT40 cells, increasing Stim1 in 
bone marrow hematopoietic progenitors might increase SOCE, enhance Ca2+-dependent Erk 
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signaling and sensitize developing B cells to negative selection. To test this hypothesis, we 
infected bone marrow hematopoietic stem cells expressing different congenic markers with 
retroviruses carrying eYFP or eYFP-Stim1. These cells were used in competitive 
repopulation experiments and the survival of eYFP-Stim1+ B cells was traced throughout 
development relative to eYFP+ B cells. eYFP-Stim1+ cells were markedly outcompeted by 
eYFP+ cells (Fig. 4), resulting in very low numbers of eYFP-Stim1+ peripheral B cells. The 
greatest loss of Stim1+ B cells occurred in bone marrow stages that correlate with the 
developmental onset of Ca2+-dependent Erk activation. Thus, increasing Stim1 expression 
confers a competitive disadvantage to developing B cells at the same stages that are most 
sensitive to thapsigargin-induced activation of Erk in unmanipulated bone marrow B lineage 
cells. To test whether this out-competition is due to increased negative selection, we 
examined the effect of Stim1 on developing MD4 transgenic B cells, which express a 
transgenic BCR that recognizes hen egg lysozyme (IgHEL). Hematopoietic stem cells 
(HSCs) from MD4 mice were infected with eYFP-Stim1 and injected into lethally irradiated 
wild-type recipient mice. The survival of eYFP-Stim1-transduced MD4 B cells relative to 
non-transduced MD4 B cells was traced throughout development. In the absence of antigen, 
MD4 B cells overexpressing eYFP-Stim1 competed efficiently with non-transduced cells 
during bone marrow development (Supplementary Fig. 3). In fact, occasionally mice 
demonstrated an expansion of eYFP-Stim1+ cells relative to non-transduced cells, an effect 
that is opposite to what was observed in mice with an unrestricted B cell repertoire. 
Therefore, restricting the BCR repertoire to IgHEL in the absence of antigen (HEL) is 
sufficient to rescue the competitive disadvantage of Stim1-overexpressing B cells. These 
findings demonstrate that Stim1 overexpression sensitizes developing B cells to negative 
selection.
RasGRP-dependent Ca2+-Erk signaling is pro-apoptotic
We next investigated the mechanism by which SOCE activates Erk to determine if a causal 
relationship between this pathway and apoptosis exists. Calcium increases are not generally 
thought to modulate the MAPK pathways leading to Erk activation. RasGrp and SOS are 
Ras guanine nucleotide exchange factors (RasGEFs) involved in RasGTP production 
upstream of Erk activation in lymphocytes25, 29–33. RasGrp proteins contain both DAG-
binding C1 domains and Ca2+-binding EF hands, and they have been proposed to mediate 
pro-apoptotic signals in B cells34, 35. Although DAG is important for RasGrp activity, we 
hypothesized that, under conditions of high SOCE, Ca2+ could potentially trigger activation 
of RasGrp as well, leading to Erk activation. We first transiently transfected 
Rasgrp1−/−Rasgrp3−/− or Sos1−/−Sos2−/− DT40 cells32 with eYFP-Stim1 and examined the 
ability of these cells to support Erk activation in response to thapsigargin. Thapsigargin-
induced Erk activation was almost entirely abrogated in Stim1-overexpressing RasGRP-
deficient cells, but was completely unaffected in SOS-deficient cells overexpressing Stim1 
(Fig. 5a). We thus generated Rasgrp1−/−Rasgrp3−/− DT40 cell lines stably overexpressing 
eYFP-Stim1 (Supplementary Fig. 4a), which exhibited a similar increase in SOCE to that 
observed in wild-type DT40 cells overexpressing Stim1 (Supplementary Fig. 4b). As 
expected after the transient transfection experiments, these cells displayed a near-complete 
loss of Erk activation in response to thapsigargin (Supplementary Fig. 4c). RasGrp 
deficiency rescued DT40 cells from BCR-induced apoptosis, even when Stim1 was 
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overexpressed (Fig. 5b). These results demonstrate that RasGrp is required to mediate Erk 
activation by Ca2+ and disrupting Ca2+-dependent activation of RasGrp and Erk is sufficient 
to inhibit antigen receptor-induced apoptosis.
PKC-mediated phosphorylation of RasGrp is known to be important for its 
activation25, 26, 36, 37. To determine whether Ca2+-dependent activation of Erk requires PKC 
activity, we examined the effect of two different PKC inhibitors, GF-109203X and Gö6976, 
on thapsigargin- or anti-BCR-induced pErk. Surprisingly, the two PKC inhibitors had 
opposite effects. GF-109203X potently inhibited the response to thapsigargin while having a 
minor effect on the anti-BCR response. Gö6976 did not inhibit the response to thapsigargin, 
but inhibited most of the anti-BCR-induced pErk response, with the remaining pErk being 
Ca2+-dependent (Fig. 5c). This result is consistent with previous studies examining the role 
of Gö6976 on BCR-induced pErk36, 37. Therefore, Gö6976 inhibits the DAG-dependent 
component of the BCR-mediated Erk response, but not the Ca2+-dependent response. In 
contrast, GF-109203X inhibits the Ca2+-dependent Erk response, but not the DAG-
dependent response. Although both of these inhibitors are known to inhibit classical PKCs 
with similar potency, their ability to inhibit non-classical PKCs is different. GF-109203X, 
but not Gö6976, can efficiently block PKCδ activity38, suggesting that this PKC isoform 
plays a critical role in Ca2+ dependent Erk signaling.
Ca2+-Erk signaling requires phospho-S332 RasGRP1
The cooperation between PKC and RasGRP proteins has been well documented, but the 
only phosphorylation site that has thus far been identified as a target of PKCs is RasGRP1 
T184, which corresponds to T133 of RasGRP3 (refs. 36, 37). Interestingly, neither of these 
sites fits a PKCδ consensus target sequence. Moreover, phosphorylation of these sites is 
blocked by Gö6976, which does not inhibit PKCδ or Ca2+-dependent Erk activation. Indeed, 
we found that T133 RasGRP3 was not phosphorylated in response to thapsigargin, and a 
T184A mutant RasGRP1 was largely functional in mediating Erk activation in response to 
SOCE (data not shown). Therefore, we hypothesized that PKCδ could potentially 
phosphorylate RasGRP on other sites and thereby induce activation of a functionally distinct 
Erk pathway. To test this hypothesis, we selected candidate sites on human RasGRP1 based 
on three criteria. One, putative sites possess a PKCδ consensus target sequence (S/
TXXR/K); two, these sites should have a predictive phosphorylation score above 0.8 on the 
Netphos 2.0 server (http://www.cbs.dtu.dk/services/NetPhos/)39; and three, sites should be 
conserved across species (chicken, mouse and human) (Supplementary Fig. 5a). Five 
potential serine or threonine sites were identified on RasGRP1, and were individually 
mutated to alanine. These mutants or wild-type human RasGRP1 were transiently 
transfected into the Stim1-overexpressing RasGRP-deficient DT40 cells. The transfected 
cells were then stimulated with thapsigargin and the pErk response within the tranfected 
population was examined. Four of the five mutant proteins were able to support Ca2+-
dependent Erk activation (Supplementary Fig. 5b). However, RasGRP1 S332A was 
completely deficient in activation of this pathway, resulting in comparably low pErk 
activation as observed in the parental RasGRP-deficient cells (Fig. 6a). The S332A mutant 
RasGRP1 was expressed in an amount comparable to that observed in wild-type RasGRP1 
transfectants (Supplementary Fig. 6), ensuring that this effect was not due to lack of 
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expression or decreased stability of the protein. We then examined the ability of this mutant 
to support DAG-mediated Erk activation.
Remarkably, when the cells were stimulated with anti-BCR in the presence of EGTA, the 
S332A mutant RasGRP1 was able to support activation of Erk, albeit less than wild-type 
RasGRP1 (Fig. 6b). This result demonstrates that the S332A mutation does not result in a 
completely inactive nucleotide exchange factor, but rather represents a crucial site that 
modulates the selective responsiveness of the exchange factor to Ca2+-induced signals. To 
further address whether S332 phosphorylation is involved in Ca2+-induced Erk activation, 
we generated a phosphomimetic S332D RasGrp1 mutant. The S332D mutant was fully 
functional and induced Erk activation in response to Ca2+ to the same extent as wild-type 
RasGRP1 (Fig. 6c). The same was true of the DAG-dependent BCR response, as measured 
by stimulation with anti-BCR in the presence of EGTA (Fig. 6d). These results demonstrate 
that phosphorylation of S332 is absolutely required for Ca2+-dependent, but not for the 
DAG-dependent BCR-induced Erk activation. Interestingly, cells expressing the 
phosphomimetic mutant RasGrp1 did not exhibit constitutive Erk activation in unstimulated 
cells, suggesting that although phosphorylation of S332 is required, it may not be sufficient 
to constitutively activate the pathway.
Given the robust impact of the S332A mutation on the ability of RasGRP1 to mediate Ca2+-
dependent Erk activation, we performed homology modeling using the ModWeb server40 
and the template mouse RasGRF1 (pdb 2IJE)41 to gain insight into the possible role this site 
could play in the regulation of RasGRP1 activity (Fig. 6e). Interestingly, this model predicts 
that S332 lies on the “flap2” region of the CDC25 domain, where a phosphorylation event 
could affect Ras binding and/or the positioning of the catalytic helical hairpin.
Developmental regulation of Stim1, RasGRP and PKCδ
To determine whether developmental regulation of protein expression might play a role in 
the selective activation of this pathway during negative selection, we sorted bone marrow B 
cell subsets and examined the expression of Stim1, PKCδ and RasGRP proteins. Consistent 
with a role for this pathway in antigen-induced apoptosis, expression of RasGRP1, 
RasGRP3, PKCδ and Stim1 were all increased at the bone marrow transitional stage, where 
negative selection occurs (Supplementary Fig. 7). This stage was also where higher 
amplitude and faster kinetics of thapsigargin-induced SOCE (Supplementary Fig. 8) and 
maximal thapsigargin-induced pErk responses occurred (Fig. 3). Expression of RasGRP1, 
PKCδ and Stim1 was then downregulated in mature B cells, while RasGRP3 abundance 
increased further in mature B cells. The pattern of PKCδ expression was consistent with 
previously published results examining expression of the LacZ gene that was introduced into 
the Prkcd locus in the Prkcd−/− mice21.
Likewise, the increase in RasGRP1 and PKCδ protein in bone marrow transitional B cells 
was also consistent with robust changes in mRNA abundance reported in the Immunological 
Genome Research Project (IMMGEN) website (http://www.immgen.org/databrowser/
index.html). These results suggest that transient increases in RasGRP1, PKCδ and Stim1 
could contribute to the preferential activation of the Ca2+-Erk pathway in developing B 
cells, and that downregulation of these proteins in mature B cells may contribute to the loss 
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of sensitivity to antigen-induced apoptosis. By contrast, the expression pattern of RasGRP3 
suggests this protein may also be involved in DAG-mediated Erk signaling in mature B 
cells.
Ca2+-Erk signaling in developing B cells requires PKCδ
The notion that PKCδ may be required for Ca2+-dependent Erk activation during B cell 
negative selection is intriguing, given the phenotype of Prkcd−/− mice21, 22. These mice 
display two-fold and seven-fold increases in B cell numbers in the spleen and lymph nodes, 
respectively. In these mice, self-reactive B cells develop, terminally differentiate, but fail to 
become anergized. The Prkcd−/− mice develop anti-nuclear antibodies and die prematurely 
at 9–12 months of age due to autoimmune disease. Previous studies on these mice have 
focused on defects in peripheral B cell homeostasis that contribute to the phenotype42. 
However, based on the developmental regulation of Ca2+-dependent Erk activation, we 
hypothesized that the phenotype of the Prkcd−/− mice may be at least partly due to an 
inability to activate the Ca2+-regulated Erk pathway during B cell negative selection. We 
performed competitive repopulation experiments, where Prkcd−/− and wild-type bone 
marrow cells were mixed at a 1:1 ratio and injected into lethally irradiated mice. As 
expected, the Prkcd−/− B cells out-competed the wild-type cells (Fig. 7a). Interestingly, the 
earliest developmental stage where this effect was observed coincided with the bone marrow 
stage where Ca2+-dependent Erk activation occurred and where increases in Stim1 
expression enhanced negative selection, whereas it was not observed in the developmental 
stages prior to antigen receptor expression. This observation suggests that the competitive 
advantage of Prkcd−/− B cells relates to alteration of developmental stage-specific signals.
We then hypothesized that the competitive advantage of Prkcd−/− bone marrow transitional 
B cells might relate to a loss of pro-apoptotic Ca2+-Erk signaling at this developmental 
stage. Thapsigargin-induced SOCE was comparable or slightly higher in Prkcd−/− cells than 
in wild-type cells (Supplementary Fig. 8). However, Ca2+-dependent Erk activation was 
markedly impaired in Prkcd−/− bone marrow developing B cells (Fig. 7b,c). The cell 
populations analyzed contain comparable numbers of newly generated B cells in both 
genotypes, as revealed by the rates of BrdU incorporation (Supplementary Fig. 9). 
Therefore, loss of Ca2+-dependent Erk signaling in transitional Prkcd−/− bone marrow B 
cells may increase survival of self-reactive B cells that would otherwise undergo apoptosis, 
thus setting the stage for the previously described autoimmune phenotype (Supplementary 
Fig. 10a,b). By contrast, enhancing activation of this pathway by increasing Stim1 
concentrations (Fig. 4) may lead to increased activation of this pathway, leading to increased 
negative selection (Supplementary Fig. 10c).
PKCδ deficiency rescues Stim1-overexpressing B cells
Lastly, we sought to examine whether the Stim1-mediated sensitization of B cells to 
negative selection in the bone marrow (Fig. 4) depends on this SOCE-PKCδ-RasGRP-Erk 
pathway. We infected wild-type or Prkcd−/− HSCs with eYFP-Stim1, then mixed at a 1:1 
ratio with eYFP-infected wild-type cells, and injected the mixed population into lethally 
irradiated recipients. The mice were analyzed 6–8 weeks post-injection, and the eYFP-
Stim1:eYFP ratio was determined throughout the bone marrow developing B cell 
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populations. As previously shown in Fig. 4, wild-type Stim1-overexpressing B cells 
displayed a competitive disadvantage at the immature and transitional stages in the bone 
marrow (Fig. 8, black bars). In contrast, Stim1-overexpressing Prkcd−/− B cells displayed a 
competitive advantage over wild-type cells expressing eYFP alone (Fig. 8, gray bars), 
indicating that PKCδ is required for Stim1 to sensitize B cells to negative selection at this 
developmental stage. Interestingly, the composition of the mature recirculating B cell 
population in these mice was highly variable (data not shown), perhaps indicative of a more 
complex epistatic relationship between PKCδ and Stim1 in peripheral B cell homeostasis. 
Nevertheless, these results further support a model where Ca2+-dependent Erk signaling, 
mediated by PKCδ and RasGRP proteins, sets a threshold for negative selection in the bone 
marrow (Supplementary Fig. 10).
Discussion
Our data reveal the existence of a Ca2+-dependent pro-apoptotic pathway to Erk activation, 
which mediates a critical checkpoint during B cell development. We therefore propose a 
model where Ca2+ and DAG can direct Erk to distinct functional outcomes during B cell 
development. Because DAG and IP3 are produced at equal molar concentrations 
downstream of PLCγ-mediated hydrolysis of PtdIns(4,5)P2, DAG production is inextricably 
linked to Ins(1,3,4)P3 -induced SOCE. However, the amplitude and duration of DAG 
production and SOCE largely depends on proteins that amplify or negatively regulate these 
second messengers. For example, higher amounts of Stim1 protein (which we observed in 
bone marrow transitional cells) may contribute to amplify SOCE. By contrast, lower DAG 
production, which have been previously reported in immature B cells10, may be the result of 
rapid DAG turn-over mediated by DAG kinases, DAG acyltransferases or DAG lipases, all 
of which metabolize DAG into different products. Data from the IMMGEN website show 
that mRNA abundance for some of these proteins, such as DGKδ, DGKτ, DGKη, DGLβ or 
DGAT2L6, change during B cell development in ways that may affect DAG metabolism. In 
addition, we have found that considerable changes in expression of proteins that mediate the 
activation of Erk pathways during development also contribute to their amplification, as 
demonstrated by the robust increases of RasGRP1 and PKCδ expression in transitional bone 
marrow B cells relative to other B cell subsets. These changes in expression are likely 
critical to setting the appropriate threshold of antigenic signal strength that results in 
negative selection.
The involvement of PKCδ in this pro-apoptotic Erk pathway is intriguing and was not 
expected. PKCδ has been implicated in apoptosis of multiple cell types43, 44, but the 
potential involvement of pro-apoptotic Ras–Erk signaling as an effector pathway 
downstream of PKCδ has not been explored. Therefore, our data implicating PKCδ in 
antigen-induced pro-apoptotic Ras–Erk signaling establish a new paradigm that could be 
tested in other systems where PKCδ is important to mediate apoptosis. It has been clearly 
demonstrated that Prkcd−/− mice display a defect in peripheral B cell homeostasis which 
increases the lifespan of B cells and is independent of selection events21, 42. However, our 
data involving PKCδ in pro-apoptotic Erk signaling during negative selection now suggest 
that loss of PKCδ may also result in previously unrecognized alterations to the B cell 
repertoire that contribute to the disease pathology of the mice. Interestingly, PKCδ has been 
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reported to be dispensable in a transgenic model of negative selection mediated by 
expression of membrane-bound hen egg lysozyme (HEL) in MD4 mice, which express 
IgHEL-specific B cells21, implying that this may not be the only pathway mediating B cell 
negative selection. However, membrane-bound HEL in that model provides an exceedingly 
strong antigenic stimulus, in particular to a high affinity BCR transgene, which may override 
mechanisms that establish selection thresholds for many antigens in normal cells, thus 
leading to B cell deletion at the earliest bone marrow immature stage45, 46. Because the 
onset of PKCδ-mediated, Ca2+-dependent Erk activation occurs in IgMhiIgDint bone marrow 
transitional B cells, it is not surprising that the mHEL system does not reveal the role of 
PKCδ in negative selection.
Ras and Erk activation have been intensively studied in lymphocytes, and have mostly been 
thought of as DAG-dependent and Ca2+-independent. Our findings demonstrate that more 
than one pathway leading to Erk activation exists in B lymphocytes, and here we show that a 
Ca2+-dependent Erk activation pathway directs the functional outcome of the stimulus 
towards an apoptotic fate in developing B cells. Because RasGRP1 is prominently and 
exclusively expressed in B cell subsets where this pathway is active, we focused on defining 
the biochemical mechanisms by which Ca2+ may influence its function. We have thus 
identified S332 on RasGRP1 as a potential phosphorylation site that is a likely PKCδ target 
and which was clearly required for Ca2+-dependent Erk activation. Unexpectedly, this site is 
located within the CDC25 domain of RasGRP1, the domain that actually mediates the 
interaction with Ras and consequently the nucleotide exchange function of the protein. 
Because of this, a phosphorylation event that preserves nucleotide exchange function (as is 
the case with S332) is unlikely to trigger structural reorganization of the protein. Based on 
homology modeling with the CDC25 of RasGRF141, 47, we predict that this site lies in the 
“flap2” region of the CDC25 domain, which may have a role in positioning the catalytic 
helical hairpin of the exchange factor for catalysis. This residue is strikingly close to the Ras 
binding site and, because of the increase in negative charge associated with phosphorylation, 
electrostatic interactions may influence the choice of Ras isoform that interacts with 
RasGRP1. This interesting idea that may help explain how distinct Ras protein signaling 
pathways that rely on Erk achieve specificity.
The Ras–Erk pathway is remarkably promiscuous in terms of potential substrates, and it has 
been suggested that specificity is achieved through compartmentalization mediated by 
scaffolds that constrain active Erk to signaling complexes where they can be activated by 
appropriate stimuli and simultaneously gain access to appropriate substrates48–50. As 
mentioned above, phosphorylation of S332 on RasGRP1 could potentially contribute to such 
specificity. However, although it is clear that phosphorylation of S332 RasGRP1 is essential 
for SOCE to induce activation of this Erk pathway, the results with the phosphomimetic 
mutant suggest that this event is also not sufficient to activate it, and that other Ca2+ -
dependent events may be required. Because PKCδ is not thought to bind Ca2+ directly, it is 
possible that Ca2+ binding to RasGRP via the EF hands contributes to promote RasGRP 
activity, possibly by facilitating the interaction with PKCδ. Moreover, at this point we 
cannot exclude the possibility that other Ca2+-responsive proteins may play a role within 
this signaling complex, perhaps by further modifying PKCδ and/or RasGRP and potentiating 
their activity. Concentration gradients of DAG and Ca2+ are also known to affect 
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localization of signaling proteins, and may contribute to directing distinct Erk pathways to 
unique compartments within the cell. Interestingly, recent results in thymocytes have 
implicated differential localization of MAPK signals in setting the thresholds of positive and 
negative selection51. These findings, combined with our data, suggest that Ca2+ and DAG 
may control selection by directing the assembly and localization of different MAPK 
signaling complexes.
Methods
Cell culture
φNX and 3T3 cells were maintained in DMEM (CellGro) supplemented with 10% FBS, 
Penicillin, Streptomycin, and L-Glutamine (complete media). DT40 cells were maintained in 
complete RPMI (Gibco) with additional 1% chicken serum and β-mercaptoethanol (Gibco). 
Rasgrp1−/−Rasgrp3−/− and Sos1−/−Sos2−/− DT40 cells were previously described32.
Mice
Prkcd−/− mice were previously described21. C57BL/6 and BoyJ mice were purchased from 
Jackson Laboratory. Mouse experiments were reviewed and approved by the Institutional 
Animal Care and Use Committee (IACUC) at UCSF.
Antibodies, reagents and inhibitors
Antibodies to murine IgD (11–26), IgM (II/41), B220 (RA3-6B2), CD45.1 (A20), CD45.2 
(104), CD43 (S7), CD21 (7G6), CD23 (B3B4), CD93 (AA4.1) conjugated to FITC, PE, 
PerCP-Cy5.5, PE-Cy7, Pacific Blue, allophycocyanin, or Alexa Fluor 647 were obtained 
from eBioscience, Biolegend or BD Biosciences. Annexin V conjugated to PE or Pacific 
Blue were from BD Biosciences and Biolegend. DAPI was from Roche. FITC-conjugated 
F(ab) monomeric fragment and goat anti-rabbit IgG Abs conjugated to allophycocyanin 
were obtained from Jackson ImmunoResearch Laboratories. CD16 antibody conjugated to 
PE or allophycocyanin was obtained from Caltag Laboratories. Phospho-Erk (#197G2), total 
Erk (#9102), RasGRP3 (C33A3) and PKCδ (#2058) antibodies were obtained from Cell 
Signaling, RasGRP1 (m199) antibody from Santa Cruz and Stim1 (#610954) antibody from 
BD. Thapsigargin, Gö6976 and GF-109203X were obtained from Calbiochem. IL-3, IL-6 
and stem cell factor were obtained from Peprotech. Lipofectamine 2000 was from 
Invitrogen. BrdU labeling was performed per manufacturer’s instructions using the BrdU 
labeling kit from BD.
Plasmids, retroviruses, transfections and infections
The pDS SP-YFP-Stim1and pEF- Flag-hDGKζ plasmids were previously described1328. For 
DT40 transfections, cells were washed and resuspended at 6.6 × 107 cells/ml in serum-free 
RPMI. The cells were electroporated at 300V for 10 msec using a square-wave 
electroporator (BTX ECM 800), rested for 15 min, and plated in complete DT40 media 
without antibiotics.
Retroviral eYFP and eYFP-Stim1 constructs were generated by subcloning these genes into 
an MSCV-IThy1.1 vector by blunt-end ligation. A peYFP-N1 plasmid (Clontech) was 
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digested with NheI and Not1, the eYFP-Stim1 plasmid with NheI and BglII, and the vector 
with NotI. All digested DNA fragments were blunted and ligated using a blunt-end ligation 
kit (Takara). Retroviruses were generated by Lipofectamine 2000 cotransfection (carried out 
per manufacturer’s instructions) of these constructs with pCL-Eco into φNX-Eco cells. 
Supernatants were collected 24 and 48 h post-transfections. 3T3 cells were infected with the 
viral supernatants and viral titers were determined based on percent eYFP-expressing cells 
by FACS. Only supernatants with titers higher than 106 particles/ml (assuming every virus 
infects a cell and a cell does not divide following infection) were used for infections of 
primary bone marrow cells. For infections, MACS-purified hematopoietic stem cells were 
incubated overnight in complete DMEM supplemented with 15% FCS, 20 ng/ml IL-3, 10 
ng/ml IL-6 and 100 ng/ml SCF. On day 2, the cells were resuspended in viral supernatant 
supplemented with 8 μg/ml polybrene, 15% FCS, 20 ng/ml IL-3, 10 ng/ml IL-6 and 100 
ng/ml SCF, and plated on 6-well plates. Cells were centrifuged for 2 h at 30 °C and 
incubated overnight at 37 °C. The infection was repeated on day 3, and injections were 
carried out on day 4 (see bone marrow reconstitutions section).
Immunoprecipitation, immunoblotting and mass spectrometry analysis
DT40 cells were lysed in 1% NP40 buffer supplemented with protease and phosphatase 
inhibitors at 107 cells/ml. Sorted bone marrow cells were lysed at 5 × 106 cells/ml. 
Immunoblotting and immunoprecipitations were performed essentially as described 
before25. For mass spectrometry analysis, 4G10 immunoprecipitates were resolved by SDS-
PAGE, stained with colloidal blue (Invitrogen), and the band of interest was excised and 
digested with trypsin. Tryptic digests were submitted to the Biomolecular Resource Center 
Mass Spectrometry Facility at UCSF for nano-electrospray LC/MS/MS and peptide mass 
fingerprint analyses.
Intracellular Ca2+ measurements
Cells were loaded with Indo-1 (Molecular Probes) per manufacturer’s instructions. Ca2+-
free and Ca2+-bound emissions were measured during stimulation of the cells using a 
fluorimeter (Hitachi F-4500 or Molecular Devices Flexstation3). Primary cells were 
analyzed by multicolor flow cytometry as previously described9.
Intracellular pErk staining
Primary bone marrow cells were harvested on pre-warmed serum-free DMEM 
supplemented with HEPES pH 7.2, non-essential aminoacids, sodium pyruvate, β-
Mercaptoethanol, penicillin, streptomycin and L-Glutamine. Cells were rested at 37 °C for 1 
h in media containing a 1:5000 dilution of non-stimulatory FITC- labeled F(ab) monomeric 
fragment, then stimulated with thapsigargin for the indicated times, fixed with pre-warmed 
cytofix (BD) for 15 min, washed twice with flow cytometry buffer, and permeabilized in 
ice-cold methanol for 45 min on ice. Cells were then washed three times, incubated for 45 
minutes in flow cytometry buffer containing pErk (Cell Signaling) antibody with 4% mouse 
serum, washed twice and stained with an anti-rabbit secondary antibody, along with 
antibodies against B220 and IgD. The cells were then analyzed by flow cytometry (as 
detailed in Supplementary methods). The same protocol was followed for DT40 cells, 
except stimulation was performed in serum- free RPMI supplemented with β-
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mercaptoethanol, and the staining was only for pErk (except for transiently transfected cells, 
which were costained for CD16).
Bone marrow reconstitutions
Bone marrow cells from donor mice as indicated for each experiment were harvested, stem 
cells were purified using a MACS stem cell purification kit (Miltenyi Biotech) and cultured 
overnight in complete media containing IL-3, IL-6 and SCF. The cells were then infected 
with retroviruses carrying eYFP or eYFP-Stim1. The cells were counted, mixed at a 1:1 
ratio, mixed with a 1:1 mixture of uninfected carrier bone marrow of the same genotype and 
injected into irradiated CD45.2+/+ host recipients. Bone marrow, spleen and lymph nodes 
from host recipients were harvested 8–10 weeks post-injection and analyzed by flow 
cytometry.
Flow Cytometry
Single cell suspensions were prepared from bone marrow, lymph nodes (LN) and spleens. 
Fc receptors were blocked with rat anti-CD16/32 (clone 2.4G2; BD Biosciences). 1–3 × 106 
cells were stained with the indicated Abs and analyzed on a FACSCalibur (BD Biosciences), 
CyAN ADP (Beckman Coulter), Gallios (Beckman Coulter) or LSRII (BD Biosciences) 
flow cytometry system. Forward and side scatter exclusion was generally used to identify 
live cells. For analysis of bone marrow chimeras, costaining with DAPI was used to exclude 
dying cells as well. Data analysis was performed using FlowJo (version 8.8.4) software 
(Tree Star). Cell sorting was performed using a MoFlo system.
Statistical analysis
Error bars were calculated as standard error of the mean with n ranging between 3 and 11 as 
indicated in each figure legend. P values for comparisons across B cell subsets were 
calculated using a paired T test, where values for each individual mouse were paired. P 
values for comparisons across different mice (of different genotype) were calculated using 
unpaired T test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Sensitization of B cells to antigen-induced apoptosis correlates with Ca2+- dependent 
Erk activation
(a) Intracellular Ca2+ measurements following stimulation with 1 μM thapsigargin or the 
anti-BCR antibody M4. Stimulation was terminated by lysis (maximum Ca2+-bound 
emissions), followed by Ca2+ chelation with EGTA (maximum Ca2+-free emissions). (b) 
Cells were stimulated for 8 h, and analyzed for surface Annexin V staining. Error bars: 
s.e.m. (n = 5 experiments) (c) Thapsigargin-stimulated cells were lysed and analyzed by 
immunoblotting with the phosphotyrosine antibodies 4G10 and RC20. (d) Phosphotyrosine-
containing proteins were immunoprecipitated with the 4G10 antibody from lysates of 
thapsigargin-stimulated Stim1-overexpressing DT40 cells. Immunoprecipitates were 
resolved by SDS-PAGE, analyzed by immunoblot (left) or stained with colloidal blue 
(right). The indicated band was excised and identified as Erk2 by mass spectrometry. This 
experiment was performed once. (e) Thapsigargin-stimulated cells were analyzed by flow 
cytometry for phospho-Erk (pErk) intensity. (f) Graph of the mean fluorescence intensity 
(MFI) for pErk over time in 1E. The data in panels a, c, e and f are representative of at least 
5 experiments each.
Limnander et al. Page 17
Nat Immunol. Author manuscript; available in PMC 2013 April 12.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
Figure 2. BCR stimulation activates Erk via two distinct pathways primarily activated by either 
Ca2+ or DAG
(a) Anti-BCR-stimulated cells were analyzed by flow cytometry for phospho-Erk (pErk) 
intensity. (b) The mean fluorescence intensity (MFI) for pErk over time was graphed. Data 
are representative of at least five independent experiments. (c,d) DT40 cells stably 
overexpressing Stim1 were transiently transfected with CD16 and either vector or DGKζ 
constructs. The cells were harvested 16–20 h post-transfection, stimulated for 5 min with 1 
μM thapsigargin or anti-BCR and the abundance of pErk was analyzed by flow cytometry. 
Surface CD16 was stained along with pErk, and served as a marker to distinguish 
transfected from untransfected populations within the same sample (gated populations 
shown in c). Histograms represent pErk response in each population as indicated, and the 
numbers indicate the percent pErk+ cells in the corresponding CD16+ population (d). The 
data in panels a-d are representative of at least 3 experiments.
Limnander et al. Page 18
Nat Immunol. Author manuscript; available in PMC 2013 April 12.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
Figure 3. Ca2+-dependent Erk activation occurs selectively at stages of negative selection in 
primary bone marrow B cells
(a) Bone marrow cells from WT C57BL/6 mice were stimulated with thapsigargin, fixed, 
permeabilized and stained for pErk along with cell surface markers. B220+ cells were gated 
in 4 subsets are defined as B220+IgM−IgD− (precursors), B220+IgM+IgD− (immature), 
B220+IgMhiIgDint (transitional), B220+IgMloIgD+ (mature recirculating) as shown in upper 
dot plot. The pErk response was analyzed for each subset. (b) Graphs of the mean 
fluorescence intensity of the pErk response for each subset over time. The data are 
representative of at least 3 experiments.
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Figure 4. Stim1 overexpression confers a competitive disadvantage to developing B cells
CD45.1+/+ or CD45.1+CD45.2+ purified bone marrow hematopoietic stem cells were 
infected with retroviruses carrying eYFP or eYFP-Stim1, respectively. Infected cells were 
mixed at a 1:1 ratio and injected with uninfected carrier bone marrow of the same genotype 
into lethally irradiated CD45.2+/+ hosts. Host mice were analyzed 8–10 weeks post-
injection. Bone marrow, splenic and lymph node cells were harvested, stained for various 
cell surface markers and analyzed by flow cytometry. The ratios of CD45.1+CD45.2+ to 
CD45.1+/+ cells were calculated for the infected (eYFP+) or uninfected (eYFP−) populations 
at various stages in B cell development (corresponding to the eYFP-Stim1+ to eYFP+ ratio 
in the infected population). Data represents one of three cohorts of reconstituted mice. Error 
bars: s.e.m. for this cohort (n = 5 mice).
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Figure 5. Activation of Erk downstream of Ca2+ requires RasGrp
(a) WT, Rasgrp1−/− Rasgrp3−/−, or Sos1−/−Sos2−/− DT40 cells were transiently transfected 
with eYFP-Stim1. Cells were stimulated with thapsigargin as indicated, fixed, permeabilized 
and stained for pErk. Results show pErk intensity in the eYFP-Stim1-expressing population. 
Data are representative of two independent experiments. (b) Cells stably overexpressing 
Stim1were stimulated for 8 h, and analyzed for surface Annexin V. Results are expressed as 
fold-increase in Annexin V+ cells relative to unstimulated cells. Error bars: s.e.m. (n = 5 
experiments). (c) WT DT40 cells stably over-expressing Stim1 were treated with the 
indicated PKC inhibitors for 5 min, stimulated with thapsigargin or anti-BCR antibody for 5 
min, and analyzed for pErk intensity. Data are representative of at least two independent 
experiments.
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Figure 6. Phosphorylation of S332 RasGRP1 is required for RasGRP1 to restore Ca2+-
dependent Erk activation in RasGRP-deficient cells
RasGRP-deficient Stim1-overexpressing cells were transiently tranfected with WT or 
mutant Myc-tagged human RasGRP1 constructs. The cells were stimulated as indicated and 
the pErk response analyzed. Plots show MFI of pErk over time following stimulation. (a,b) 
Effect of S332A mutation on the pErk response induced by thapsigargin (a) or by BCR 
crosslinking in the presence of EGTA (b) Data are representative of at least four 
independent experiments. (c,d) Effect of S332D mutation on the pErk response induced by 
thapsigargin (c) or by BCR crosslinking in the presence of EGTA (d). Data are 
representative of two independent experiments (e) The three-dimensional structure of the 
Cdc25 domain of mouse RasGRP1 was modeled using the ModWeb server and the template 
mouse RasGRF1 (pdb 2IJE). The potential phosphorylation site at serine 332 (blue sticks) 
was found to be in flap2 abutting the helical hairpin. Residues within 3.2 Å of S332 are 
shown in stick representation.
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Figure 7. PKCδ is required for Ca2+-dependent Erk activation in developing bone marrow cells
(a) Prkdc−/− and WT bone marrow cells bearing different CD45 congenic markers were 
mixed at a 1:1 ratio and injected into lethally irradiated hosts. Mice were analyzed 6–8 
weeks post injection. Graph shows the ratio of Prkdc−/− to WT cells throughout B cell 
development. Data represents one of two cohorts of mice. Error bars: s.e.m. (n = 8 mice) (b) 
Prkcd−/− and WT control bone marrow cells were stimulated with thapsigargin as indicated. 
The pErk response was analyzed by flow cytometry. (c) Fold-induction of the MFI of pErk 
in 3A in each bone marrow subset with respect to resting cells. Data are representative of at 
least four independent experiments.
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Figure 8. PKCδ is required for Stim1-mediated sensitization of bone marrow B cells to negative 
selection
CD45.1+/+ HSCs were infected with retroviruses carrying eYFP and mixed 1:1 with eYFP-
Stim1-infected CD45.2+/+ HSCs from either WT or Prkdc−/− mice. The cells were injected 
with uninfected carrier bone marrow of the same genotype into lethally irradiated CD45.1+/+ 
CD45.2+/+ hosts. Host mice were analyzed 8–10 weeks post-injection as described in Fig. 4. 
Data represents one of three cohorts of mice. Error bars: s.e.m. (n = 11 mice reconstituted 
with eYFP-Stim1-infected Prkdc−/− cells and n = 8 mice reconstituted with eYFP-Stim1-
infected WT cells).
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